EIN Presswire
Sensor Bio Welcomes Dr. Michael Poku as Clinical Advisor
By Sensor Bio ·
Physician executive and value-based care leader joins advisory team as Sensor Bio expands its clinical foundation
The company is building a landmark platform around continuous biometric data, and I look forward to supporting the team as it develops thoughtful clinical and commercial applications
AUSTIN, TX, UNITED STATES, June 8, 2026 /EINPresswire.com/ -- Sensor Bio, the continuous biometric signal infrastructure platform built for clinical, enterprise, and AI health applications, today announced that Dr. Michael Poku has joined the company as a Clinical Advisor. Dr. Poku currently serves as Chief Clinical Officer at Equality Health.
Dr. Poku's experience bridging clinical practice and health system transformation makes him a natural fit for Sensor Bio's mission to bring open, medical-grade biometric infrastructure to population-scale healthcare.
"I am excited to join Sensor Bio as a clinical advisor. The company is building a landmark platform around continuous biometric data, and I look forward to supporting the team as it develops thoughtful clinical and commercial applications," said Dr. Michael Poku, Clinical Advisor, Sensor Bio.
"Having Dr. Poku in our corner reflects where Sensor Bio is headed," said Bruce Smith, CEO, Sensor Bio. "He understands what it takes to move health technology from promising to proven inside real health systems. That perspective is invaluable as we scale."
About Dr. Michael Poku Dr. Michael Poku is a physician executive with deep expertise in value-based care, clinical leadership, and health technology. He currently serves as Chief Clinical Officer at Equality Health, where he leads clinical strategy for one of the nation's leading value-based care organizations. He also serves as a healthcare advisor to General Atlantic. [Full credentials, fellowships, and additional affiliations to be confirmed with Dr. Poku prior to publication.]
About Sensor Bio Sensor Bio is the continuous biometric signal layer powering the future of AI health. The company provides an open, medical-grade wearable platform covering hardware, firmware, and enterprise data infrastructure that captures unfiltered physiological signals for clinical programs, AI health applications, and enterprise deployments. Backed by 29 peer-reviewed studies and a decade of R&D, Sensor Bio is the only open, medical-grade platform built for enterprise scale.